Takeshi Kimura

Summary

Affiliation: Ajinomoto Co
Country: Japan

Publications

  1. ncbi Plasma amino acid analysis for diagnosis and amino acid-based metabolic networks
    Takeshi Kimura
    Quality Assurance and External Scientific Affairs Department, Ajinomoto Co, Inc, Tokyo, Japan
    Curr Opin Clin Nutr Metab Care 12:49-53. 2009
  2. ncbi Summary of workshop discussions on establishing upper limits for amino acids with specific attention to available data for the essential amino acids leucine and tryptophan
    Takeshi Kimura
    Ajinomoto Co, Inc, Chuo Ku, Tokyo, Japan
    J Nutr 142:2245S-2248S. 2012
  3. ncbi The 7th workshop on the assessment of adequate intake of dietary amino acids: summary of general discussion
    Takeshi Kimura
    Ajinomoto Co, Inc, Quality Assurance and External Scientific Affairs Department, 104 8315 Tokyo, Japan
    J Nutr 138:2050S-2205S. 2008
  4. ncbi Screening of toxicity biomarkers for methionine excess in rats
    Sakino Toue
    Ajinomoto Co, Inc, Institute of Life Sciences, Kawasaki, Japan
    J Nutr 136:1716S-1721S. 2006
  5. ncbi Potential approaches to the assessment of amino acid adequacy in rats: a progress report
    Ryosei Sakai
    Institute of Life Sciences and Research Institute for Health Fundamentals, Ajinomoto Co, Inc, Kawasaki, Japan
    J Nutr 134:1651S-1655S; discussion 1664S-1666S, 1667S-1672S. 2004
  6. ncbi Metabolomics and its potential for assessment of adequacy and safety of amino acid intake
    Yasushi Noguchi
    Research Institute for Health Fundamentals and Institute of Life Sciences, Ajinomoto Co, Inc, Tokyo 210-8681, Japan
    J Nutr 133:2097S-2100S. 2003
  7. ncbi Prolonged oral treatment with an essential amino acid L-leucine does not affect female reproductive function and embryo-fetal development in rats
    Kazunori Mawatari
    Amino Acids Department, Ajinomoto Co, Inc, 1-15-1 Chuo-ku, Tokyo 104-8315, Japan
    Food Chem Toxicol 42:1505-11. 2004

Collaborators

Detail Information

Publications7

  1. ncbi Plasma amino acid analysis for diagnosis and amino acid-based metabolic networks
    Takeshi Kimura
    Quality Assurance and External Scientific Affairs Department, Ajinomoto Co, Inc, Tokyo, Japan
    Curr Opin Clin Nutr Metab Care 12:49-53. 2009
    ..To highlight the usefulness of amino acid profiling in clinical diagnosis and current developments in analysis revealing underlying metabolic relationships...
  2. ncbi Summary of workshop discussions on establishing upper limits for amino acids with specific attention to available data for the essential amino acids leucine and tryptophan
    Takeshi Kimura
    Ajinomoto Co, Inc, Chuo Ku, Tokyo, Japan
    J Nutr 142:2245S-2248S. 2012
    ..Animal results obtained in pigs and rodents were discussed and 2 possible strategies for applying those outcomes to humans were described...
  3. ncbi The 7th workshop on the assessment of adequate intake of dietary amino acids: summary of general discussion
    Takeshi Kimura
    Ajinomoto Co, Inc, Quality Assurance and External Scientific Affairs Department, 104 8315 Tokyo, Japan
    J Nutr 138:2050S-2205S. 2008
    ..There was recognition that regardless of the available data, there is regulatory pressure for setting upper levels of intake for amino acids and that much more data are required...
  4. ncbi Screening of toxicity biomarkers for methionine excess in rats
    Sakino Toue
    Ajinomoto Co, Inc, Institute of Life Sciences, Kawasaki, Japan
    J Nutr 136:1716S-1721S. 2006
    ..Collectively from these results, homocysteine appeared to be the most plausible biomarker to assess methionine excess as a surrogate marker both for toxicity and for setting a metabolic upper limit...
  5. ncbi Potential approaches to the assessment of amino acid adequacy in rats: a progress report
    Ryosei Sakai
    Institute of Life Sciences and Research Institute for Health Fundamentals, Ajinomoto Co, Inc, Kawasaki, Japan
    J Nutr 134:1651S-1655S; discussion 1664S-1666S, 1667S-1672S. 2004
    ..This suggested that >8.9 g/kg BW, the catabolism of L-leucine changed and this approximately coincided with the dose above which a statistically significant decrease in body weight was seen...
  6. ncbi Metabolomics and its potential for assessment of adequacy and safety of amino acid intake
    Yasushi Noguchi
    Research Institute for Health Fundamentals and Institute of Life Sciences, Ajinomoto Co, Inc, Tokyo 210-8681, Japan
    J Nutr 133:2097S-2100S. 2003
    ..We suggest that these basic concepts and methods could serve as the basis for a metabolomic approach for the assessment of the range of adequacy of amino acid intakes...
  7. ncbi Prolonged oral treatment with an essential amino acid L-leucine does not affect female reproductive function and embryo-fetal development in rats
    Kazunori Mawatari
    Amino Acids Department, Ajinomoto Co, Inc, 1-15-1 Chuo-ku, Tokyo 104-8315, Japan
    Food Chem Toxicol 42:1505-11. 2004
    ..These results suggested that L-leucine, administered orally during organogenesis at doses up to 1000 mg/kg body weight, did not affect the outcome of pregnancy and did not cause fetotoxicity in rats...